Webinars & Videos

5-year Evolut Low Risk Data: Durable clinical outcomes, outstanding valve performance
The late-breaking five-year results of the Evolut Low-Risk Trial presented at the American College of Cardiology (ACC) 2025 meeting in late March, showed positive results for the Evolut transcatheter aortic valve replacement (TAVR) system vs. surgical aortic valve replacement (SAVR).
Challenges of Diagnosing CAD in Women
Diagnosing female patients with coronary artery disease (CAD) has many challenges. Join us to hear from three key opinion leaders as they present data and new case studies demonstrating these difficulties, and the guidelines and pathways that help with diagnosis and management of women with suspected CAD.
Electrophysiology Innovation at Texas Cardiac Arrhythmia Institute
Most advancements in electrophysiology technology are small and incremental, but the experts at Texas Cardiac Arrhythmia Institute in Austin, TX, were quick to see distinct advantages when they started using the latest iteration of radio frequency ablation, the QDOT MICRO™ Catheter.
SMART 2-year TAVR hemodynamic data: Medtronic Evolut is better compared to Edwards Sapien in small annulus patients
Howard Herrmann, MD, MSCAI, Hospital of the University of Pennsylvania, and lead invesigator for the SMART trial, explains details on the 2-year data comparing the Evolut vs. Sapien 3 for TAVR in small annulus patients.
Wellstar's CCTA + Heartflow Program Impact: Improving Patient Care While Driving Financial Growth
If you’re looking to grow your CCTA program or start one, listen in. Learn from cardiology and radiology experts at Wellstar Health System who have built a successful CCTA program.

Future of Echocardiography: Unlocking the Power of Volume Imaging

Join Dr. Dinesh Thavendiranathan of the University of Toronto for a discussion on 3D volume echocardiography in the left heart.

C-suite CV Executives Prepare for an Evolving Landscape

Remote Patient Monitoring: Economic, Medical & Legal Considerations

St. Jude Medical

Despite data supporting the clinical benefits of remote monitoring, some practices are resisting adoption due to the potential liability of receiving alerts on a 24-hour basis. Four experts share their opinions on how practices should approach these considerations.

Optimizing PCI Outcomes: The Right Tools for the Best Results

St. Jude Medical

To optimize outcomes for PCI procedures, new technologies have emerged to assist interventionalists with patient selection, clinical decision making and post-stent assessment.

The Economic & Practical Considerations of Utilizing FFR

St. Jude Medical

Since the clinical benefits of fractional flow reserve (FFR) were confirmed with the release of the FAME study in January 2009, the technology has gained wider adoption. To assess its impact on contemporary cath labs, five interventionalists came together from across the U.S. to discuss the economic considerations.

Cardiology PACS & CVIS: Implementing Digital Strategies

Webinars & Videos

5-year Evolut Low Risk Data: Durable clinical outcomes, outstanding valve performance

Challenges of Diagnosing CAD in Women

Electrophysiology Innovation at Texas Cardiac Arrhythmia Institute

SMART 2-year TAVR hemodynamic data: Medtronic Evolut is better compared to Edwards Sapien in small annulus patients

Wellstar's CCTA + Heartflow Program Impact: Improving Patient Care While Driving Financial Growth